相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study
Shinsuke Hidese et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2023)
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
Joel Simren et al.
ALZHEIMERS & DEMENTIA (2021)
Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism
Alexander Pilozzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
Kah Kheng Goh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
Borjanka Batinic et al.
FRONTIERS IN PSYCHIATRY (2021)
Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
Yongfeng Yang et al.
FRONTIERS IN PSYCHIATRY (2019)
The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
Yue Zhu et al.
FRONTIERS IN PSYCHIATRY (2019)
Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia
Peiyan Ni et al.
COMPREHENSIVE PSYCHIATRY (2019)
The Role of Proopiomelanocortin and α-Melanocyte-Stimulating Hormone in the Metabolic Syndrome in Psychiatric Disorders: A Narrative Mini-Review
Stefan Raue et al.
FRONTIERS IN PSYCHIATRY (2019)
Assessment of neuropsychological performance in Mexico City youth using the Cambridge Neuropsychological Test Automated Battery (CANTAB)
Rivka Green et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2019)
Reduced plasma orexin-A levels in patients with bipolar disorder
Shoko Tsuchimine et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
Tomas Hokfelt et al.
FRONTIERS IN NEURAL CIRCUITS (2018)
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
M. O. Trepanier et al.
MOLECULAR PSYCHIATRY (2016)
Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide
Swapnali Barde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis
Jian-Ping Zhang et al.
SCHIZOPHRENIA BULLETIN (2016)
Global economic burden of schizophrenia: a systematic review
Huey Yi Chong et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis
Elizabeth Reisinger Walker et al.
JAMA PSYCHIATRY (2015)
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset
M. K. Chan et al.
TRANSLATIONAL PSYCHIATRY (2015)
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen et al.
MEDICINAL RESEARCH REVIEWS (2015)
Association of Neurotensin Receptor 1 Gene Polymorphisms with Processing Speed in Healthy Chinese-Han Subjects
Man Wang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Neuropeptide Systems and Schizophrenia
Amber LaCrosse et al.
CNS & Neurological Disorders-Drug Targets (2013)
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Viktoria Kormos et al.
NEUROPEPTIDES (2013)
The Role of Oxytocin in Psychiatric Disorders: A Review of Biological and Therapeutic Research Findings
David M. Cochran et al.
HARVARD REVIEW OF PSYCHIATRY (2013)
G protein-linked signaling pathways in bipolar and major depressive disorders
Hiroaki Tomita et al.
Frontiers in Genetics (2013)
Oxytocin: a therapeutic target for mental disorders
Mitsuhiro Matsuzaki et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2012)
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Guy Griebel et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia
Daimei Sasayama et al.
SCHIZOPHRENIA RESEARCH (2012)
Altered Sleep and Affect in the Neurotensin Receptor 1 Knockout Mouse
Karrie Fitzpatrick et al.
SLEEP (2012)
Endogenous Opiates in the Nucleus Tractus Solitarius Mediate Electroacupuncture-Induced Sleep Activities in Rats
Chiung-Hsiang Cheng et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Neurotensin Receptor 1 Gene (NTSR1) Polymorphism Is Associated with Working Memory
Jin Li et al.
PLOS ONE (2011)
Age-Related Differences in Plasma Proteins: How Plasma Proteins Change from Neonates to Adults
Vera Ignjatovic et al.
PLOS ONE (2011)
Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia
Cort A. Pedersen et al.
SCHIZOPHRENIA RESEARCH (2011)
Involvement of α-MSH in the social isolation induced anxiety- and depression-like behaviors in rat
Dadasaheb M. Kokare et al.
NEUROPHARMACOLOGY (2010)
Study Design, Precision, and Validity in Observational Studies
Melissa D. A. Carlson et al.
JOURNAL OF PALLIATIVE MEDICINE (2009)
The role of beta-endorphin in the pathophysiology of major depression
K. M. Hegadoren et al.
NEUROPEPTIDES (2009)
Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment
Saliha Ozsoy et al.
PSYCHIATRY RESEARCH (2009)
Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2009)
Substance P depolarizes striatal projection neurons and facilitates their glutamatergic inputs
Craig Blomeley et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
NEUROPEPTIDE Y GENE POLYMORPHISM AND PLASMA NEUROPEPTIDE Y LEVEL IN FEBRILE SEIZURE PATIENTS IN TAIWAN
Lung-Chang Lin et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2007)
Effects of treatment latency on response to maintenance treatment in manic-depressive disorders
Ross J. Baldessarini et al.
BIPOLAR DISORDERS (2007)
Neurotensin activates GABAergic interneurons in the prefrontal cortex
KA Petrie et al.
JOURNAL OF NEUROSCIENCE (2005)
Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice
PJ Peeters et al.
MOLECULAR BRAIN RESEARCH (2004)
Neuropeptides involved in the pathophysiology of schizophrenia and major depression
David De Wied et al.
NEUROTOXICITY RESEARCH (2002)
Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence
A Carlsson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Prolactin and beta-endorphin serum elevations after ECT in manic patients
HR Chaudhry et al.
ACTA PSYCHIATRICA SCANDINAVICA (2000)
分享论文
